KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Gains from Investment Securities (2017 - 2025)

Amneal Pharmaceuticals (AMRX) has 9 years of Gains from Investment Securities data on record, last reported at $24.2 million in Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 5468.29% year-over-year to $24.2 million; the TTM value through Sep 2025 reached $28.9 million, up 283.8%, while the annual FY2024 figure was $8.0 million, 154.85% up from the prior year.
  • Gains from Investment Securities reached $24.2 million in Q3 2025 per AMRX's latest filing, up from -$5.9 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $24.2 million in Q3 2025 and bottomed at -$18.2 million in Q4 2021.
  • Average Gains from Investment Securities over 5 years is -$625500.0, with a median of $146500.0 recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: plummeted 4877.88% in 2022, then surged 5468.29% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at -$18.2 million in 2021, then skyrocketed by 90.35% to -$1.8 million in 2022, then crashed by 854.83% to -$16.7 million in 2023, then surged by 141.7% to $7.0 million in 2024, then soared by 247.26% to $24.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $24.2 million in Q3 2025, -$5.9 million in Q2 2025, and $3.6 million in Q1 2025.